MSH|^~\&|LAB|QUL||4827620|20051103091117||ORU^R01|20051103510779720000|P|2.3|||||||
PID|1||SS0160686|20685|TestLastName^TestFirstName||19630824|M||||||||||20685|||||||||||||
ORC|RE|20685|SS0160686||CM|||||||^WOO^^||||||||
OBR|1|20685|SS0160686|88888^*REPORT COMMENTS^^88888^*REPORT COMMENTS|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|TX|88888^*REPORT COMMENTS^^88888^*REPORT COMMENTS^||SEE NOTE|||N|||F|||20051103053500|SC^^L|||
NTE|1||FASTING|
OBR|2|20685|SS0160686|8000^ COMPREHENSIVE METABOLIC PANEL^^8000^ COMPREHENSIVE METABOLIC PANEL|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|30005^SODIUM, SERUM^^30005^SODIUM, SERUM^||139|mmol/L|135-146|N|||F|||20051103053500|SC^^L|||
OBX|2|NM|30010^POTASSIUM, SERUM^^30010^POTASSIUM, SERUM^||4.4|mmol/L|3.5-5.3|N|||F|||20051103053500|SC^^L|||
OBX|3|NM|30015^CHLORIDE, SERUM^^30015^CHLORIDE, SERUM^||100|mmol/L|98-110|N|||F|||20051103053500|SC^^L|||
OBX|4|NM|30020^CARBON DIOXIDE (CO2)^^30020^CARBON DIOXIDE (CO2)^||27|mmol/L|16-26|H|||F|||20051103053500|SC^^L|||
OBX|5|NM|30025^UREA NITROGEN,BLOOD (BUN)^^30025^UREA NITROGEN,BLOOD (BUN)^||21|mg/dL|7-25|N|||F|||20051103053500|SC^^L|||
OBX|6|NM|30030^CREATININE, SERUM^^30030^CREATININE, SERUM^||0.8|mg/dL|0.5-1.4|N|||F|||20051103053500|SC^^L|||
OBX|7|NM|30035^GLUCOSE^^30035^GLUCOSE^||169|mg/dL|65-99|H|||F|||20051103053500|SC^^L|||
OBX|8|NM|30045^CALCIUM, SERUM^^30045^CALCIUM, SERUM^||9.5|mg/dL|8.5-10.4|N|||F|||20051103053500|SC^^L|||
OBX|9|NM|30060^TOTAL PROTEIN^^30060^TOTAL PROTEIN^||6.7|g/dL|6.0-8.3|N|||F|||20051103053500|SC^^L|||
OBX|10|NM|30065^ALBUMIN^^30065^ALBUMIN^||4.3|g/dL|3.5-4.9|N|||F|||20051103053500|SC^^L|||
OBX|11|NM|30070^GLOBULIN, TOTAL^^30070^GLOBULIN, TOTAL^||2.4|g/dL|2.0 - 4.0|N|||F|||20051103053500|SC^^L|||
OBX|12|NM|30075^A/G RATIO^^30075^A/G RATIO^||1.8|ratio|1.0 - 2.5|N|||F|||20051103053500|SC^^L|||
OBX|13|NM|30085^AST (SGOT)^^30085^AST (SGOT)^||19|U/L|3-50|N|||F|||20051103053500|SC^^L|||
OBX|14|NM|30090^BILIRUBIN, TOTAL^^30090^BILIRUBIN, TOTAL^||0.4|mg/dL|0.2-1.5|N|||F|||20051103053500|SC^^L|||
OBX|15|NM|30110^ALT (SGPT)^^30110^ALT (SGPT)^||39|U/L|3-60|N|||F|||20051103053500|SC^^L|||
OBX|16|NM|30115^ALKALINE PHOSPHATASE^^30115^ALKALINE PHOSPHATASE^||97|U/L|20-125|N|||F|||20051103053500|SC^^L|||
OBR|3|20685|SS0160686|9651^LIPID PROFILE^^9651^LIPID PROFILE|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|30120^CHOLESTEROL, TOTAL^^30120^CHOLESTEROL, TOTAL^||209|mg/dL|<200|H|||F|||20051103053500|SC^^L|||
OBX|2|NM|30125^TRIGLYCERIDES^^30125^TRIGLYCERIDES^||158|mg/dL|<150|H|||F|||20051103053500|SC^^L|||
OBX|3|NM|30126^VLDL CHOLESTEROL (CALCULATED)^^30126^VLDL CHOLESTEROL (CALCULATED)^||32|mg/dL|5 - 40|N|||F|||20051103053500|SC^^L|||
OBX|4|NM|30128^LDL CHOLESTEROL (CALCULATED)^^30128^LDL CHOLESTEROL (CALCULATED)^||139|mg/dL|0 - 129|H|||F|||20051103053500|SC^^L|||
OBX|5|NM|39405^CHOLESTEROL, HDL^^39405^CHOLESTEROL, HDL^||38|mg/dL|>40|L|||F|||20051103053500|SC^^L|||
OBX|6|NM|39406^CHOLESTEROL/HDL RATIO^^39406^CHOLESTEROL/HDL RATIO^||5.5||SEE NOTE|N|||F|||20051103053500|SC^^L|||
NTE|1||Reference Range: AVE. RISK 4.5-6.4|
NTE|2||     CARDIAC RISK FACTOR:   AVERAGE RISK |
OBX|7|NM|39408^LDL/HDL RATIO^^39408^LDL/HDL RATIO^||3.66||SEE NOTE|N|||F|||20051103053500|SC^^L|||
NTE|1||Reference Range: AV.RISK 2.25-4.90|
NTE|2||                            AVERAGE RISK|
OBR|4|20685|SS0160686|35010^CBC WITH DIFFERENTIAL (AUTOMATED)^^35010^CBC WITH DIFFERENTIAL (AUTOMATED)|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|35001^WHITE BLOOD COUNT^^35001^WHITE BLOOD COUNT^||8.9|Thous/mcL|4.1-11.3|N|||F|||20051103053500|SC^^L|||
OBX|2|NM|35002^RED BLOOD COUNT^^35002^RED BLOOD COUNT^||5.43|Mill/mcL|4.20-5.50|N|||F|||20051103053500|SC^^L|||
OBX|3|NM|35003^HEMOGLOBIN^^35003^HEMOGLOBIN^||15.9|g/dL|13.0-18.0|N|||F|||20051103053500|SC^^L|||
OBX|4|NM|35004^HEMATOCRIT^^35004^HEMATOCRIT^||46.5|%|37.5-54.0|N|||F|||20051103053500|SC^^L|||
OBX|5|NM|35005^MCV^^35005^MCV^||86|fL|80.0-103.0|N|||F|||20051103053500|SC^^L|||
OBX|6|NM|35006^MCH^^35006^MCH^||29.3|pg|27.0-34.0|N|||F|||20051103053500|SC^^L|||
OBX|7|NM|35007^MCHC^^35007^MCHC^||34.2|g/dL|31.0-36.0|N|||F|||20051103053500|SC^^L|||
OBX|8|NM|35008^RED CELL DIST. WIDTH^^35008^RED CELL DIST. WIDTH^||12.7|%|10.8-14.8|N|||F|||20051103053500|SC^^L|||
OBX|9|NM|35009^NEUTROPHILS^^35009^NEUTROPHILS^||66|%|45 - 75|N|||F|||20051103053500|SC^^L|||
OBX|10|NM|35011^LYMPHOCYTES^^35011^LYMPHOCYTES^||25|%|20 - 45|N|||F|||20051103053500|SC^^L|||
OBX|11|NM|35012^MONOCYTES^^35012^MONOCYTES^||8|%|1 - 13|N|||F|||20051103053500|SC^^L|||
OBX|12|NM|35013^EOSINOPHILS^^35013^EOSINOPHILS^||1|%|0 - 6|N|||F|||20051103053500|SC^^L|||
OBX|13|NM|35014^BASOPHILS^^35014^BASOPHILS^||0|%|0 - 2|N|||F|||20051103053500|SC^^L|||
OBX|14|NM|35016^NEUTROPHILS (ABS VALUE)^^35016^NEUTROPHILS (ABS VALUE)^||5.84|Thous/mcL|1.50-8.00|N|||F|||20051103053500|SC^^L|||
OBX|15|NM|35017^LYMPHOCYTES (ABS VALUE)^^35017^LYMPHOCYTES (ABS VALUE)^||2.20|Thous/mcL|0.80-3.20|N|||F|||20051103053500|SC^^L|||
OBX|16|NM|35018^MONOCYTES (ABS VALUE)^^35018^MONOCYTES (ABS VALUE)^||0.75|Thous/mcL|0.0-1.1|N|||F|||20051103053500|SC^^L|||
OBX|17|NM|35019^EOSINOPHILS (ABS VALUE)^^35019^EOSINOPHILS (ABS VALUE)^||0.094|Thous/mcL|0.00-0.50|N|||F|||20051103053500|SC^^L|||
OBX|18|NM|35020^BASOPHILS (ABS VALUE)^^35020^BASOPHILS (ABS VALUE)^||0.000|Thous/mcL|0.000-0.200|N|||F|||20051103053500|SC^^L|||
OBX|19|NM|35021^PLATELET COUNT^^35021^PLATELET COUNT^||204|Thous/mcL|150-400|N|||F|||20051103053500|SC^^L|||
OBX|20|ST|35026^DIFFERENTIAL TYPE^^35026^DIFFERENTIAL TYPE^||AUTO|||N|||F|||20051103053500|SC^^L|||
OBR|5|20685|SS0160686|39157^HEMOGLOBIN A1C IMMUNOASSAY^^39157^HEMOGLOBIN A1C IMMUNOASSAY|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|39161^HEMOGLOBIN A1C^^39161^HEMOGLOBIN A1C^||7.8|%||H|||F|||20051103053500|SC^^L|||
NTE|1|| |
NTE|2||NON DIABETIC:     <6.0%|
OBX|2|NM|39162^MEAN PLASMA GLUCOSE^^39162^MEAN PLASMA GLUCOSE^||200|mg/dL||N|||F|||20051103053500|SC^^L|||
NTE|1||GLYCOHEMOGLOBIN, A1C REFERENCE RANGES:                                |
NTE|2||                                                                      |
NTE|3||                 NONDIABETIC     GOAL    ADDITIONAL ACTION SUGGESTED  |
NTE|4||                 -----------     ----    ---------------------------  |
NTE|5||HbA1C(%)             <6           <7                 >8               |
NTE|6||                                                                      |
NTE|7||Factors such as duration of diabetes, adherence to therapy, and       |
NTE|8||patient age should be considered in assessing blood glucose control.  |
NTE|9||Suggested values are for non-pregnant individuals.  "Additional action|
NTE|10||suggested" depends on individual patient circumstances and should be  |
NTE|11||interpreted with respect to the complete patient presentation.|
OBR|6|20685|SS0160686|39770^CREATININE, URINE^^39770^CREATININE, URINE|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|39772^CREATININE, URINE^^39772^CREATININE, URINE^||120|mg/dL||N|||F|||20051103053500|SC^^L|||
OBR|7|20685|SS0160686|42500^TSH, (3RD GENERATION)^^42500^TSH, (3RD GENERATION)|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|42500^TSH (HIGH SENSITIVITY)^^42500^TSH (HIGH SENSITIVITY)^||1.87|ulU/L|0.40-5.50|N|||F|||20051103053500|SC^^L|||
OBR|8|20685|SS0160686|42920^PROSTATE SPECIFIC ANTIGEN (PSA)^^42920^PROSTATE SPECIFIC ANTIGEN (PSA)|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|42926^PSA (BAYER)^^42926^PSA (BAYER)^||0.4|ng/mL|< OR = 4.0|N|||F|||20051103053500|SC^^L|||
NTE|1|| |
NTE|2||PSA VALUES FROM DIFFERENT ASSAY METHODS CANNOT BE USED|
NTE|3||INTERCHANGEABLY. THIS ASSAY WAS PERFORMED USING THE BAYER|
NTE|4||CHEMILUMINESCENCE METHOD STARTING ON AUGUST 2, 2004.|
OBR|9|20685|SS0160686|56811^MICROALBUMIN CONC.^^56811^MICROALBUMIN CONC.|||20051102200000|||||||20051102181800||^WOO^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103053500|||F|||||||||||||||||||
OBX|1|NM|56811^MICROALBUMIN CONC.^^56811^MICROALBUMIN CONC.^||11|mg/L|Less than 22|N|||F|||20051103053500|SC^^L|||
OBX|2|NM|56825^ALB/CREAT. RATIO^^56825^ALB/CREAT. RATIO^||9.17|mcg/mg|0.0 - 29.0|N|||F|||20051103053500|SC^^L|||
NTE|1||Values greater than 30 mcg albumin/mg creatinine are operationally|
NTE|2||defined as microalbuminuria in samples collected from ambulatory|
NTE|3||subjects not undergoing vigorous exercise.  In patients with diabetes|
NTE|4||mellitus or essential hypertension, the amount of microalbuminuria is|
NTE|5||increased by exercise; in early diabetes, good glycemic control can|
NTE|6||eliminate exercise-induced microalbuminuria.  If the influence of|
NTE|7||exercise and poor glycemic control is minimized, microalbuminuria is a|
NTE|8||good predictor of progression to overt nephropathy in both|
NTE|9||insulin-dependent and non insulin-dependent diabetes.  Normalization|
NTE|10||of blood glucose and blood pressure can delay the progression from|
NTE|11||microalbuminuria to clinical nephropathy.|
